Beta Bionics Q4 EPS $(0.30) Beats $(0.42) Estimate, Sales $32.121M Beat $30.243M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Beta Bionics (NASDAQ:BBNX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.42) by 28.06 percent. This is a 88.97 percent increase over losses of $(2.72) per share from the
Beta Bionics (NASDAQ:BBNX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.42) by 28.06 percent. This is a 88.97 percent increase over losses of $(2.72) per share from the same period last year. The company reported quarterly sales of $32.121 million which beat the analyst consensus estimate of $30.243 million by 6.21 percent. This is a 57.15 percent increase over sales of $20.440 million the same period last year.